Employment of Mapping Technology in Antimicrobial Resistance Reporting in Saudi Arabia
Accepted: 4 March 2020
HTML: 67
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Although Antimicrobial Resistance (AMR) is a worldwide threat, local AMR databases do not exist. Unlike other health disasters, developing containment strategies for AMR cannot be started without a representative, local, updated AMR data. However, Geographical Information Systems (GIS) mapping technology is capable of visualizing AMR data integrated with geographical regions. Due to the absence of AMR databases in Saudi Arabia, we searched Medline and Embase databases from inception until May 28, 2018, including literature that reported AMR data on the most prevalent gram-negative bacterial strains in Saudi Arabia. These data were extracted into Microsoft Excel file and inserted into STATA software, version 13 and ArcMap 10.6 software platform for mapping. We found particularly high levels of AMR in Makkah (Mecca), possibly due to high antibiotic consumption because of the influx of pilgrims, with Pseudomonas aeruginosa isolates showing the highest resistance rate against amikacin, aztreonam, cefepime, ceftazidime, ciprolfloxacin, gentamicin, imipenem, meropenem and pipracillin/tazobactam, and Enterobacteriaceae isolates against cefuroxime, ciprofloxacin, ampicillin, imipenem and ertapenem. The cause is, however, multifactorial since Acinetobacter baumannii isolates showed a variable resistance rate throughout the country. The employment of mapping technology in displaying AMR data extracted from published literature is a practically useful approach, and advanced GIS analyses should help stakeholders create containment strategies and allocate resources to slow down the emergence of AMR.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
-
Thamer A. Almangour, Leen Ghonem, Dareen Alassiri, Alanoud Aljurbua, Mohammed Al Musawa, Aminah Alharbi, Sara Almuhisen, Jeelan Alghaith, Nader Damfu, Doaa Aljefri, Wafa Alfahad, Marwan Alrasheed, Yaqoub Khormi, Abdullah AlmohaizeieJournal of Infection and Chemotherapy : 2024
-
Abdul Haseeb, Mohammed A. S. Abourehab, Wesam Abdulghani Almalki, Abdulrahman Mohammed Almontashri, Sultan Ahmed Bajawi, Anas Mohammed Aljoaid, Bahni Mohammed Alsahabi, Manal Algethamy, Abdullmoin AlQarni, Muhammad Shahid Iqbal, Alaa Mutlaq, Saleh Alghamdi, Mahmoud E. Elrggal, Zikria Saleem, Rozan Mohammad Radwan, Ahmad Jamal Mahrous, Hani Saleh FaidahInternational Journal of Environmental Research and Public Health : 2022
-
Abdul Haseeb, Mayyasah Khalid Alqurashi, Areej Sultan Althaqafi, Jumana Majdi Alsharif, Hani Saleh Faidah, Mashael Bushyah, Amal F. Alotaibi, Mahmoud Essam Elrggal, Ahmad Jamal Mahrous, Safa S. Almarzoky Abuhussain, Najla A. Obaid, Manal Algethamy, Abdullmoin AlQarni, Asim A. Khogeer, Zikria Saleem, Muhammad Shahid Iqbal, Sami S. Ashgar, Aziz SheikhAntibiotics : 2022
-
Abdul Haseeb, Zikria Saleem, Hani Saleh Faidah, Abdullah A. Saati, Abdullmoin AlQarni, Muhammad Shahid Iqbal, Saleh Alghamdi, Mahmoud E. Elrggal, Manal AlGethamy, Rozan Mohammad Radwan, Ahmad Jamal Mahrous, Safa S. Almarzoky Abuhussain, Sarah M. Khayyat, Kiran Ibrahim, Brian Godman, Aziz SheikhAntibiotics : 2023
-
Thamer A. Almangour, Leen Ghonem, Dareen Alassiri, Alanoud Aljurbua, Mohammed Al Musawa, Aminah Alharbi, Abdullah Almohaizeie, Sara Almuhisen, Jeelan Alghaith, Nader Damfu, Doaa Aljefri, Wafa Alfahad, Yaqoub Khormi, Menyfah Q. Alanazi, Yazed Saleh AlsowaidaAntimicrobial Agents and Chemotherapy : 2023
-
Abdullah Alsultan, Shereen A. Dasuqi, Fadi Aljamaan, Rasha A. Omran, Saeed Ali Syed, Turki AlJaloud, Abdullah AlAhmadi, Saeed Alqahtani, Mohammed A. HamadSaudi Pharmaceutical Journal : 2021